This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...
As everyone knows, Monster Beverage (NASDAQ:MNST) has been a stock that has given spectacular returns to its shareholders so far for decades. It has...
BiomX logo (BiomX website) BiomX Inc. (NYSE:PHGE) is a clinical-stage biotech company that develops bacteriophage (“phage”) cocktails to treat various diseases utilizing its next-generation...
Back in March, I placed a “Sell” rating on Beyond Meat (NASDAQ:BYND), saying management greatly misread demand for its product. I reiterated my “Sell”...
Investment Thesis In my opinion, Bristol-Myers Squibb (NYSE:BMY) stands at a critical juncture. My forthcoming analysis contends that the company’s valuation and future market...
In my last post, I initiated coverage of Algoma Steel (NASDAQ:ASTL), explaining my reasoning that through Algoma Steel’s current cost model with its Basic...